Form D · Biotechnology

Voltron Therapeutics, Inc.

New York, NY · CIK 0001835742

Offering snapshot reported Nov 9, 2023 · SEC filing

Reported sold
$3.21M
Indefinite offering
Investors reported
63
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 28, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.61M$3.21MNov 9, 2022: $515,000.00Nov 9, 2022Nov 9, 2023: $3,210,680.00Nov 9, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$515,000 → $3,210,680
  • Reported investors8 → 63

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2023Amendment$3,210,680$2,695,680vs Nov 9, 202263SEC filing
Nov 9, 2022Initial$515,000No comparison8SEC filing
Jun 16, 2022Initial$300,000No comparison1SEC filing
Sep 1, 2021Initial$2,502,011No comparisonNot reportedSEC filing
Jul 13, 2021Initial$3,349,428No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$385K (estimated)
Finders' fees
$0
Form D file number
021-464374

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Laidlaw & Company (UK) Ltd.119037

Source: Form D, filed Nov 9, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Ahern Director
Matthew Duffy Director, Executive
Matthew Eitner Director
Patrick Gallagher Director, Executive
Paul Korner Director
Anthony Zook Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
12 E 49 Th Street 11 Th Floor
New York, NY, 10017